Trimethylamine N-oxide (TMAO) is a microbial metabolite that exhibited synergism with anti-PD-1 antibodies by promoting CD8+ T cell-mediated anti-tumor immunity in a triple-negative breast cancer (TNBC) mouse model [164]. The gene discussed is CD8A; the disease is neoplasm.